Testosterone binds to the androgen receptor with a low nanomolar affinity, while the stronger biological action of DHT is mediated by its two-fold higher affinity and five-fold lower rate of dissociation from the AR compared to testosterone. These findings suggest that hypogonadal levels of testosterone dysregulate mood and induce depressive symptoms that can be ameliorated by testosterone treatment, but TRT is unlikely to be an antidepressant treatment for major depressive disorder. In 2014, a meta-analysis of six studies of testosterone treatment in eugonadal and hypogonadal men, including the above three studies, concluded that TRT improved mood and decreased depressive symptoms in men with low to hypogonadal levels of total testosterone . The result is a profound reduction in circulating levels of testosterone and dihydrotestosterone, by up to 97% without any change in SHBG. A recent meta-analysis of hypothalamic-pituitary–gonadal dysregulation in depression raised the caveat that new LH and FSH assays with greater sensitivity and improved quality control should be used to reassess the role of gonadotropin secretion  in depression. Other research has shown that testosterone may exert an antidepressant action by activating androgen receptor MAPK-ERK2 signaling in the hippocampus . In addition to regulating the HPG axis via kisspeptin signaling, testosterone also regulates kisspeptin neurons in the amygdala and hippocampus .
An increase in thyroid hormone levels due to therapy with L-thyroxine causes an increase in the Adiponectin gene expression, while the treatment with dexamethasone leads to opposite effect . There is a positive correlation between the adiponectin levels and the T production, because the T synthesis also depends on gonadotropins with LH activity . In addition, the expression of the Adiponectin gene was detected in the pituitary gland 142, 143, 144, whereby the regulators of the adiponectin receptors in gonadotrophs can be both plasma and pituitary adiponectin (Figure 2). The inhibitory effect of adiponectin on LH production can be carried out at the pituitary level, since both adiponectin receptors were detected in the LH-expressing gonadotrophs of human and rats 14, 142, 143. This can be caused by the reduced intratesticular levels of leptin or the decreased sensitivity of testicular cells to this adipokine that participates in the regulation of survival and proliferation of Leydig cells (Figure 1). In men with obesity, metabolic syndrome and DM2, the activity of the male HPG axis and the T production are decreased, which lead to androgen deficiency 95, 96, 97.
Men with normal total testosterone levels had a considerably longer depression-free survival period . When clinical criteria for hypogonadism are used, consistent  increases in depressive symptomatology and incidence of clinical depression  have been reported in hypogonadal men with confirmed testosterone deficiency compared to eugonadal men with testosterone levels in the normal physiological range. Subsequently, observational, cross-sectional, or longitudinal studies reported an inverse relationship of depression scores in men with circulating testosterone levels in the low physiological and hypogonadal ranges, while other studies did not find a relationship of depressive symptoms and testosterone levels 20, 25, 26. The complex, multilevel regulation of the hypothalamic-pituitary–gonadal axis is mediated by stimulatory and inhibitory neurocircuits acting on gonadotropin-releasing hormone (GnRH) neurons in the arcuate/infundibular nucleus and medial preoptic area of the hypothalamus. Regulation of the hypothalamic-pituitary–gonadal axis, testicular synthesis of androgens, and physiological actions of testosterone resulting from androgen receptor signaling in targeted tissues. However, studies on the interaction of testosterone levels with depression and the antidepressant effect of testosterone replacement therapy in hypogonadal men with depression have been inconclusive.
We evaluated the composition and advertised claims of "T boosting" supplements, and supporting published evidence. A zero LH on a man who is producing abundant testosterone through an exogenous source is not the same finding as a zero LH on a man with no hormonal explanation. The hypothalamus has received the signal, the pituitary has responded accordingly, and the feedback loop is intact. A specialist in men's health or hormone optimization can also help bridge the gap if your primary care provider is uncomfortable managing these results. What specifically concerns you about this result given that I am on exogenous testosterone? Certain medications can also interact with or independently suppress the HPG axis, so a full medication review with your provider is always a sound practice. These options exist and are used regularly in the context of hormone optimization. have been undertaken on the relationship between more general aggressive behavior, and feelings, and testosterone. Nearly all studies of juvenile delinquency and testosterone are not significant.|Currently, there is evidence that leptin not only indirectly affects the steroidogenesis in Leydig cells through the regulation of the HPG axis but is also capable of directly affecting the activity of steroidogenesis system 3, 8. GnRH and NPY increase the leptin expression by pituitary gonadotrophs, while the gastrointestinal hormone ghrelin, the regulator of food intake and the functional antagonist of leptin, on the contrary, suppresses the ob gene expression 69, 72. In rats the pituitary leptin level varies significantly during the postnatal development, and in female rats it changes at the different stages of the estrous cycle and during pregnancy . The functions of the autonomous leptin system in the pituitary, its participation in gonadotropins production and the relationship between the activity of this system and the physiological state of the HPG axis are supported by the following facts. At the same time, under conditions of prolonged administration of leptin, an increase in LH level or lack of leptin effect on LH secretion were detected, which may be assumed to be due to varying degrees of leptin resistance in the case of long-term action of leptin on hypothalamic neurons. This review presents the comprehensive analysis of the involvement of leptin, adiponectin, resistin and visfatin in the regulation of the male HPG axis and steroidogenesis, as well as of the possible mechanisms of this regulation. Some adipokines can also directly affect the functions of Leydig cells, as indicated by a high level of adipokines expression in the testes, as well as detection of the main components of the adipokine signaling, including adipokine-specific receptors, in testicular cells, including Leydig cells 16, 17, 18, 19.|It is important to note that the inhibition of ERK1/2 activity is due to an increase in AMPK activity . When adiponectin binds to AdipoR1, the APPL-1/APPL-2 complex dissociates, resulting in the release of APPL-1 to interact with the downstream effector proteins 116, 130. The interaction of adiponectin-activated AdipoR1 with APPL-1 leads to the activation of AMPK and the 3-phosphoinositide and MAPK cascades.|The findings of these two studies indicate that men with prostate cancer and a history of depression are especially vulnerable to the depressogenic effect of ADT. Recently, however, three studies with large sample sizes and statistical control of variables have shown a strong association of ADT with a depression diagnosis. In an Asian cohort, the rate of incident depression over a three-year period was 13.9% in men with prostate cancer treated with ADT who had no prior diagnosis of a depressive disorder . The rate of depression is significantly higher in men with prostate cancer compared to cancer-free men . These systemic changes can lead to coronary artery disease, type 2 diabetes, and dyslipidemia, and increase the risk of developing depression 49–51. ADT results in many adverse physiological effects, far more frequent and intense than occurring in clinical hypogonadism, which includes severe fatigue, increased adiposity and obesity, dyslipidemia, insulin resistance, cardiovascular dysregulation, sarcopenia, osteoporosis and fractures, sexual dysfunction, and increased inflammation 47, 48. Androgen deprivation therapy (ADT) is the first line treatment for advanced, metastatic, and recurrent prostate cancer due to its ability to dramatically reduce circulating testosterone.}
Shorter CAG repeat lengths confer higher affinity and sensitivity of the androgen receptor to testosterone and DHT while longer CAG repeat lengths render the androgen receptor less sensitive to androgens 99, 100. After binding testosterone or DHT, the cytosolic androgen receptor assumes an active confirmation, dissociates from these cytoplasmic proteins, and translocates to the nucleus where the activated AR dimerizes and functions as a ligand-dependent nuclear transcriptional regulator (Fig. 1). Androgen receptor expression has been found to be decreased by 2.7-fold in hypothalamus of men with major depressive disorder compared to male controls .
Continuous secretion of GnRH uncouples the gonads from pituitary regulation and leads to decreased synthesis of gonadotropins and hypogonadism. The pulsatile release of GnRH by hypothalamic neurons is necessary for adequate gonadotropin production by the pituitary. Gonadotropin-releasing hormone (GnRH) is secreted from the hypothalamus by GnRH-expressing neurons. Patients should be informed that "T booster" supplements may not have components with mechanisms to support their claims. Despite the FDA statement against the use of supplements to treat conditions, 90% of "T booster" supplements claimed to boost T. However, despite these limitations, our data clearly demonstrates the unrealistic expectations that are stated online for the role of vitamins and antioxidants in male infertility.
The HPG axis can also be suppressed by GnRH antagonists or continuous administration of GnRH agonist, such as in the following applications Also as a result, many of the side effects are similar to the symptoms of pregnancy. Although often described as preventing pregnancy by mimicking the pregnancy state, hormonal birth control is effective because it works on the HPG axis to mimic the luteal phase of a woman's cycle. Hormone replacement can be used to initiate puberty and continue if the gene mutation occurs in the gene coding for the hormone. A mutation that causes a gain of function for LH receptors can result in a condition known as testotoxicosis, which causes puberty to occur between ages 2–3 years. For example, the male mutation of the GnRH coding gene could result in hypogonadotrophic hypogonadism.. Adiponectin inhibits both the basal and GnRH-stimulated LH secretion, and its effect is detected even after a short exposure with gonadotrophs 14, 144.|Importantly, recent research has shown that genetic factors can regulate the trajectory of testosterone during aging 21–23. Several studies have shown that certain chronic medical disorders, especially type 2 diabetes, may be more important in promoting testosterone decline than increasing age 2, 16, 19, 20. Furthermore, it is well established that the rate of testosterone decline can be accelerated by modifiable lifestyle factors including obesity and alcohol consumption. Although most studies on testosterone decline during aging have involved older men, a recent longitudinal study of young, healthy men (average age 34) found that the age at baseline did not predict changes in the trajectories of testosterone, dihydrotestosterone, androstenedione, and estradiol measured by LC–MS/MS mass spectrometry over a twelve-year period . A smaller number of longitudinal studies reported a greater rate of testosterone decline during aging with total testosterone decreasing by 1–2% per year 15, 16. Other men, however, experience a substantial age-related decline in total testosterone into the clinical hypogonadal range below 280–300 ng/dl (9.7–10.4 nmol/L SI units).|In males, these are usual late pubertal effects, and occur in women after prolonged periods of heightened levels of free testosterone in the blood. Pubertal effects begin to occur when androgen has been higher than normal adult female levels for months or years. For postnatal effects in both males and females, these are mostly dependent on the levels and duration of circulating free testosterone. Both testosterone and DHT bind to an androgen receptor; however, DHT has a stronger binding affinity than testosterone and may have more androgenic effect in certain tissues at lower levels. Subsequent neuroendocrine research including meta-analyses  have found that basal testosterone levels and 24-h testosterone secretion are abnormally low in men with major depressive episodes 25, 36, 43. The role of hypothalamic–pituitary–adrenal hypersecretion observed in severe major depressive episodes and the well-known ability of high cortisol to suppress the hypothalamic-pituitary–gonadal axis in the relationship of testosterone and depression requires further investigation.|While different search times produced results that were not relevant to this study, such as products with exogenous T and hormones, a different search phrase may have produced a varied supplement list. In addition, only the first and most frequently appearing 50 supplements were included in the study, acknowledging that other products and supplements may be available that were not studied here. However, despite this FDA statement, the "T booster" supplements made a host of claims.|Dysregulation of the hypothalamic-pituitary–gonadal (HPG) axis has been observed in patients with major depressive episodes. In 2006, a Canadian study reported that total and bioavailable testosterone were significantly lower in middle-aged depressed men (40–65 years) who had considerably higher BDI and Hamilton depression scores than men enrolled in the Rancho Bernardo Study . Preclinical research has provided further evidence that androgens may reduce the risk of depression in men due to their antidepressant and neuroprotective actions in the hippocampus, limbic system, and other brain regions regulating mood 12, 13.|Given these findings, 15 individual supplements (13.8%) therefore had conflicting data regarding their effect on T. Eleven individual supplements (10.1%) had data showing a decrease in T with supplementation, and 20 individual supplements (18.3%) had data showing no change in T with supplementation. For 27 individual supplements (24.8%), there was data showing an increase in T with supplementation. For 13 supplements (11.9%) there were 2 studies; for 3 supplements (2.8%) there were 3 studies; for 4 supplements (3.7%) there were 4 studies; for 1 supplements (0.9%) there were 5 studies; for 1 supplements (0.9%) there were 6 studies. For 19 supplements (17.4%) there was a single study looking at the effect of supplementation on T. The claims and the number of supplements claiming these benefits are detailed in Table 2. Most frequently, claims to "boost T or free T", "build body lean mass or muscle mass", or "increase sex drive or libido" were advertised by the supplements.|Fasting and i.c.v. administration of leptin lead to a significant decrease in the intratesticular level of resistin, while in diet-induced obesity the expression of resistin in the testes remained unchanged . Resistin was found in the brain and CSF, and although its concentration was much lower than in the bloodstream, it can be assumed that resistin affects the activity of hypothalamic neurons controlling GnRH secretion 116, 133. Using the primary culture of pituitary cells of rhesus monkey it was shown that resistin activates a number of signaling pathways, including cAMP-dependent and 3-phosphoinositide cascades regulating the cell survival and secretory activity.}
It should be noted, however, that the treatment of pituitary cells with leptin and adiponectin also did not affect LH secretion, which is probably due to the peculiarities of cultured cells used in the experiment . Adiponectin is able to control steroidogenic function in the testes directly, acting on Leydig cells, and indirectly, acting on the HPG axis at the hypothalamic and pituitary levels. The ob gene is expressed in gonadotrophs, although the data on the number of pituitary cells that produce leptin and on the co-expression of leptin and pituitary hormones differ significantly 15, 71, 72. Meanwhile, the plasma level of growth hormone and the expression of growth hormone receptors in the hypothalamus were decreased, which indicates an impairment of the somatotropic axis. There is a good reason to believe that pituitary leptin functions as a paracrine and autocrine regulator controlling the survival and functional activity of gonadotrophs, since the plasma leptin can not mediate the complex pattern of pituitary hormone secretion . The most important in the regulation of reproductive functions is NPY, which, by binding to the receptors Y1 and Y5 on the GnRH-neurons , suppresses GnRH expression and lowers the plasma LH levels 61, 62.

Gender: Female

Social links